Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Brodalumab

Eczematous reactions

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Alsenaid A, et al. Brodalumab-Induced Eczematous Reactions in Psoriasis Patients: Management With Switching to Risankizumab. Journal of Cutaneous Medicine and Surgery 27 : 236-240, No. 3, Jan 2023. Available from: URL: 10.1177/12034754231167140 Alsenaid A, et al. Brodalumab-Induced Eczematous Reactions in Psoriasis Patients: Management With Switching to Risankizumab. Journal of Cutaneous Medicine and Surgery 27 : 236-240, No. 3, Jan 2023. Available from: URL: 10.1177/12034754231167140
Metadaten
Titel
Brodalumab
Eczematous reactions
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-55481-8

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Tozinameran

Case report

Norepinephrine

Case report

Mycophenolate

Case report

Bedaquiline